Repurposing 1,2,4-oxadiazoles as SARS-CoV-2 PLpro inhibitors and investigation of their possible viral entry blockade potential
Mohammed Salah Ayoup, Mariam M. ElShafey, Hamida Abdel‐Hamid, Doaa A. Ghareeb, Marwa M. Abu‐Serie, Lamia Heikal, Mohamed Teleb
Topics & Concepts
ChemistryDocking (animal)IC50Viral replicationViral entryOxadiazoleProteasesPeptidomimeticStereochemistryDrug repositioningBiochemistryVirusPharmacologyDrugIn vitroVirologyEnzymeBiologyPeptideNursingOrganic chemistryMedicineSARS-CoV-2 and COVID-19 ResearchComputational Drug Discovery MethodsMosquito-borne diseases and control